Reblozyl 75 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FRD5F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,771
Award facts
- Contract value 100% obligated
- $31,770.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $31,770.69 delivery order to Amerisourcebergen Drug Corp on May 6, 2026, for REBLOZYL 75 MG vials, with an ultimate completion date of May 28, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a pharmaceutical distributor supplying medications and medical devices to federal healthcare systems and the Department of Defense as a prime contractor on full-and-open competitive awards.
Quick answers
Who was awarded contract SPE2DR26FRD5F?
SPE2DR26FRD5F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 6, 2026.
How much is contract SPE2DR26FRD5F worth?
The government has obligated $31,771 on SPE2DR26FRD5F.
Is contract SPE2DR26FRD5F an order under another contract?
Yes. SPE2DR26FRD5F is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FRD5F competed?
The extent of competition for SPE2DR26FRD5F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award